Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations (SpringerPlus, (2015), 4, 54, 10.1186/s40064-015-0827-8)

Nattinger, A. B., Pezzin, L. E., McGinley, E. L., Charlson, J. A., Yen, T. W. F., & Neuner, J. M. (2015, December 26). Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations (SpringerPlus, (2015), 4, 54, 10.1186/s40064-015-0827-8). SpringerPlus. SpringerOpen. https://doi.org/10.1186/s40064-015-1233-y